Antisense oligonucleotide treatment reveals a physiologically relevant role for adrenomedullin gene products in sodium intake

Brain Research

Volumn 818, Issue 1, 1999, Pages 164-167

  Samson, Willis K ^a   Bode, Ann M ^a   Murphy, Tonya C ^a   Resch, Zachary T ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Adrenomedullin; Antisense; Salt appetite

Indexed keywords

ADRENOMEDULLIN; ANTISENSE OLIGONUCLEOTIDE; GENE PRODUCT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; APPETITE; ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE; TISSUE SPECIFICITY;

ADRENOMEDULLIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; HOMEOSTASIS; MALE; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM;

EID: 0033528249     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01268-2     Document Type: Article

References (13)

1. Andreis P.G., Mazzocchi G., Rebuffat P., Nussdorfer G.G. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci. 60:1997;1693-1697.
2. Blackburn R.E., Samson W.K., Fulton R.J., Stricker E.M., Verbalis J.G. Central oxytocin and atrial natriuretic peptide mediate the osmotic inhibition of salt appetite in rats. Am. J. Physiol. 269:1995;R245-R251.
3. Jougasaki M., Wei C.M., Aarhus L.L., Heublein D.M., Sandberg S.M., Burnett J.C. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am. J. Physiol. 268:1995;F657-F663.
4. Katoh F., Kitamura K., Niina H., Yamamoto R., Washimine H., Kangawa K., Yamamoto Y., Kobayashi H., Eto T., Wada A. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J. Neurochem. 64:1995;459-461.
5. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
6. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
7. Murphy T.C., Samson W.K. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology. 136:1995;2459-2463.
8. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:1994;105-108.
9. Samson W.K. Proadrenomedullin-derived peptides. Frontiers in Neuroendocrinology. 19:1998;100-127.
10. Samson W.K., McDonald J.K., Lumpkin M.D. Naloxone dissociates stress-induced oxytocin and prolactin releases. Neuroendocrinology. 40:1985;68-70.
11. Samson W.K., Murphy T.C. Adrenomedullin inhibits salt appetite. Endocrinology. 138:1996;613-616.
12. Samson W.K., Murphy T.C., Resch Z.T. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am. J. Physiol. 274:1998;R1505-R1509.
13. Ueta Y., Kitamura K., Isse T., Shibuya I., Kabashima N., Yamamoto S., Kangawa K., Matsuo H., Eto T., Yamashita H. Adrenomedullin-like immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci. Lett. 202:1995;251-254.